Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease. Scope of the Report: This report focuses on the Drugs for Malaria in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Cipla Guilin Pharmaceutical IPCA Laboratories GlaxoSmithKline Mylan Labs Roche Novartis Sanofi Aventis Ajanta Pharma Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds Market Segment by Applications, can be divided into Prevention Treatment Other There are 17 Chapters to deeply display the United States Drugs for Malaria market. Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Drugs for Malaria, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Drugs for Malaria market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents 1 Market Overview 1.1 Drugs for Malaria Introduction 1.2 Market Analysis by Type 1.2.1 Aryl Aminoalcohol Compounds 1.2.2 Antifolate Compounds 1.2.3 Artemisinin Compounds 1.3 Market Analysis by Applications 1.3.1 Prevention 1.3.2 Treatment 1.3.3 Other 1.4 Market Analysis by States 1.4.1 California
